$BIIB Recent News Internet, biotech could spawn next

New Post Public Reply Private Reply Replies (0) Message Board

Apr 29, 2014 at 9:34 AM

$BIIB Recent News

Internet, biotech could spawn next Apple: Allianz CIO 7:12 a.m. Today - Barbara Kollmeyer
Investors gloss over Biogen earnings miss and focus on MS drug sales 2:23 p.m. April 23, 2014 - blogs.marketwatch.com
Scouring the moonscape for leading stocks 3:01 p.m. April 22, 2014 - The Trading Deck
Apple, Microsoft are not the keys to this week’s news 7:00 a.m. April 22, 2014 - Marek Fuchs
Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski
Biotech misses out on Nasdaq rally, sinks further into bear ground 4:58 p.m. April 14, 2014 - blogs.marketwatch.com
Herbalife sinks on probe fears; Zoe’s surges on debut 4:36 p.m. April 11, 2014 - Ben Eisen
Stocks fall for 3rd day in row; S&P 500 down for year again: stock market live blog recap 4:11 p.m. April 7, 2014 - blogs.marketwatch.com
Biotech bargain? 11:43 a.m. April 1, 2014 - The Trading Deck
Facebook, Biogen, Cal-Maine are stocks to watch 5:21 a.m. March 31, 2014 - Victor Reklaitis
U.S. stocks end week with losses 7:17 p.m. March 28, 2014 - Anora Mahmudova
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - blogs.marketwatch.com
U.S. stocks fall; Nasdaq skids 1.2% 4:40 p.m. March 24, 2014 - Anora Mahmudova
Biotech has second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - blogs.marketwatch.com
First Solar extends winning streak; Symantec plunges 3:06 p.m. March 21, 2014 - Ben Eisen
Investors let air out of biotech amid overheating, pricing concerns 1:42 p.m. March 21, 2014 - blogs.marketwatch.com
U.S. stocks rise; S&P 500 positive for the year 4:39 p.m. March 17, 2014 - Anora Mahmudova
Yahoo gains on Alibaba IPO; Plug Power loses momentum 4:17 p.m. March 17, 2014 - Saumya Vaishampayan
Keurig Green Mountain added to S&P 500 index 9:56 a.m. March 15, 2014 - MarketWatch.com

Biogen to Present Plegridy Data from Phase 3 Study at AAN Annual Meeting 6:31 a.m. Today - benzinga.com
If You Want GARP, Look Into Biotech, Not Utilities, But Do The Valuations 11:35 a.m. April 28, 2014 - Seeking Alpha
Why Gilead Sciences (GILD) Stock Is Up Today 11:16 a.m. April 28, 2014 - TheStreet.com
Stock Market News for April 28, 2014 - Market News 10:06 a.m. April 28, 2014 - Zacks.com
Disappointments? Think Opportunities; Miracle Drug May Be Ailing Gilead: Jim Cramer's Best Blogs 6:00 a.m. April 26, 2014 - TheStreet.com
Amgen Blazed Biotech Trail, Earned 165,233% Reward 5:51 p.m. April 25, 2014 - Investors Business Daily
3 Stocks Reiterated As A Buy: EBAY, AXP, BIIB 3:59 p.m. April 25, 2014 - TheStreet.com
Spectrum Pharma Candidate Gets Positive Data - Analyst Blog 5:50 p.m. April 24, 2014 - Zacks.com
Gilead, Alexion, Biogen, Or Celgene: 1 Mindboggling Metric Identifies The Best Value! 4:57 p.m. April 24, 2014 - Seeking Alpha
3 Drugs Stocks Dragging The Industry Down 1:03 p.m. April 24, 2014 - TheStreet.com
Stock Market News for April 24, 2014 - Market News 10:06 a.m. April 24, 2014 - Zacks.com
Ambit Biosciences Slumps: AMBI Falls 7.1% in Session - Tale of the Tape 8:49 a.m. April 24, 2014 - Zacks.com
Prothena Corporation plc (PRTA) Worth Watching: Stock Rises 9.5% - Tale of the Tape 8:44 a.m. April 24, 2014 - Zacks.com
Biogen partners with Quintiles to beef up its clinical development processes 8:18 a.m. April 24, 2014 - Seeking Alpha
Biogen Idec Inc. (BIIB): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. April 24, 2014 - Zacks.com
Quintiles, Biogen Idec Announce Comprehensive Clinical Development Partnership 7:01 a.m. April 24, 2014 - benzinga.com
After the Apple Split, Five More Bull Market Stock Splits Needed 6:39 a.m. April 24, 2014 - 247WallSt.com
Biogen Idec's CEO Discusses Q1 2014 Earnings Results - Earnings Call Transcript 10:54 p.m. April 23, 2014 - Seeking Alpha
Will Today Be the Day the Dow Finally Does It? 9:11 p.m. April 23, 2014 - InvestorPlace.com
Biogen Q1, Guidance Strong, But Stock Slips 5:46 p.m. April 23, 2014 - Investors Business Daily

Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth 3:31 p.m. April 28, 2014 - PR Newswire - PRF
Strategic Collaborations, Fresh Agreements, and Upcoming Conferences - Analyst Notes on Biogen, Bristol-Myers, AbbVie, Actavis and Bard 8:00 a.m. April 28, 2014 - PR Newswire - PRF
Quintiles and Biogen Idec Announce Comprehensive Clinical Development Partnership 8:01 a.m. April 24, 2014 - BusinessWire - BZX
Biogen Idec Signs License Agreement With Amunix for XTENylated Factor VIII 8:02 a.m. April 21, 2014 - Marketwire
RBCC Bioprinting Partner Expands Brand Awareness Campaign 4:28 a.m. April 16, 2014 - BusinessWire - BZX
Surveyed European Neurologists Expect to Prescribe Biogen Idec's Tecfidera to 16 Percent of their Diagnosed Relapsing-Remitting Multiple Sclerosis Patients in the Next 12 Months 1:00 p.m. April 15, 2014 - PR Newswire - PRF
Legal Updates, Stock Price Movements, New Awareness Campaigns, and Senior-level Appointments - Analyst Notes on Mylan, WellPoint, Forest, Novatis and Intercept 8:00 a.m. April 15, 2014 - PR Newswire - PRF
Biogen Idec to Present New Clinical Data from Its Robust Neurology Portfolio at AAN Annual Meeting 7:30 a.m. April 14, 2014 - BusinessWire - BZX
JPMorgan Chase First Quarter Earnings Falls 20 Percent; FBI Probes Herbalife Business 12:36 a.m. April 14, 2014 - ACCESSWIRE
Pfizer’s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts 9:00 a.m. April 11, 2014 - BusinessWire - BZX
Biogen Idec Names Adam M. Koppel as SVP and Chief Strategy Officer 7:30 a.m. April 10, 2014 - BusinessWire - BZX
Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase-3 paediatric study of investigational therapy Eloctate(TM) (rFVIIIFc) for haemophilia A 7:06 a.m. April 10, 2014 - Thomson Reuters ONE
Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety Results from Phase 3 Pediatric Study of Investigational Therapy Eloctate™ (rFVIIIFc) for Hemophilia A 7:00 a.m. April 10, 2014 - BusinessWire - BZX
RBCC and n3D Seek Out Additional Capital 5:00 a.m. April 9, 2014 - BusinessWire - BZX
Earnings Release Schedules, Product Portfolio Expansion, Initiatives and Stock Price Movements - Analyst Notes on Biogen Idec, Bristol-Myers, Regeneron Pharma, Illumina, West Pharma Services 8:00 a.m. April 8, 2014 - PR Newswire - PRF
Bioprinting Investment Puts RBCC at Forefront of 3-D Revolution 5:00 a.m. April 3, 2014 - BusinessWire - BZX
Biogen Idec to Report First Quarter 2014 Financial Results on April 23, 2014 4:01 p.m. March 31, 2014 - BusinessWire - BZX
Sobi: US FDA approves Alprolix(TM) 2:05 a.m. March 31, 2014 - GlobeNewswire
Sobi: US FDA approves Alprolix(TM) 2:01 a.m. March 31, 2014 - Thomson Reuters ONE
FDA Approves Biogen Idec’s ALPROLIX™, the First Hemophilia B Therapy to Reduce Bleeding Episodes with Prophylactic Infusions Starting at Least a Week Apart 6:34 p.m. March 28, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beko Pushes for Policy Synergy Amidst Carbon Shakeup

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Retirement Dreams Dashed: 61% Withdraw Early

By Olivia Taylor Updated Nov 14, 2026 Category News Views 298

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

EFICYENT Ventures to Connect at Singapore FinTech Fest

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

El Pollo Loco Faces Class Action Over Wage Practices

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...